130 related articles for article (PubMed ID: 6222948)
21. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas.
Indrová M; Bubeník J
Folia Biol (Praha); 1979; 25(2):137-41. PubMed ID: 456694
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of subpopulations of immune lymphocytes against murine sarcoma cells.
Lamon EW; Wigzell H
Transplantation; 1974 Oct; 18(4):368-71. PubMed ID: 4547517
[No Abstract] [Full Text] [Related]
23. Host immunity to growing sarcomas: tumor-specific serum inhibition of tumor-specific cellular immunity.
Cohen AM
Cancer; 1973 Jan; 31(1):81-9. PubMed ID: 4509387
[No Abstract] [Full Text] [Related]
24. [Kinetics of populations of theta+ and theta- cells in the lymph nodes of KR/j mice during methylcholanthrene carcinogenesis].
Iudin VM; Fedorovskaia MI; Umanskiĭ IuA
Vopr Onkol; 1976; 22(3):54-60. PubMed ID: 1084623
[No Abstract] [Full Text] [Related]
25. Specific antigens on methylcholanthrene-induced tumors of mice.
Lennox ES; Lowe AD; Cohn J; Evan G
Transplant Proc; 1981 Dec; 13(4):1759-61. PubMed ID: 6173943
[No Abstract] [Full Text] [Related]
26. Stimulation of transplanted 3-methylcholanthrene-induced sarcomas in mice by specific immune ahd by normal serum.
Biddle C
Int J Cancer; 1976 Jun; 17(6):755-64. PubMed ID: 947855
[TBL] [Abstract][Full Text] [Related]
27. The role of blocking antibodies in immunological enhancement.
Takasugi M; Klein E
Immunology; 1971 Oct; 21(4):675-84. PubMed ID: 5121758
[TBL] [Abstract][Full Text] [Related]
28. Syngeneic monoclonal antibodies to a methylcholanthrene-induced mouse sarcoma.
Lennox E; Cohn J; Lowe T
Transplant Proc; 1980 Mar; 12(1):95-8. PubMed ID: 7368297
[No Abstract] [Full Text] [Related]
29. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
Konda S; Smith RT
Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
[No Abstract] [Full Text] [Related]
30. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.
Morishita H; Shiku H; Horibe K; Obata Y; Stockert E; Oettgen HF; Old LJ; Yamada K
J Exp Med; 1986 Feb; 163(2):452-7. PubMed ID: 3003228
[TBL] [Abstract][Full Text] [Related]
31. [Immunotherapy of malignant tumors with subpopulations of T lymphocytes].
Fernández-Cruz E
Rev Esp Oncol; 1982; 29(4):701-10. PubMed ID: 6242320
[TBL] [Abstract][Full Text] [Related]
32. Study of the immunogenic strength of sarcomas induced in diffusion chambers.
Parmiani G; Carbone G; Lembo R
Schweiz Med Wochenschr; 1972 Aug; 102(33):1151-2. PubMed ID: 5055035
[No Abstract] [Full Text] [Related]
33. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas.
Indrová M; Bubeník J
Neoplasma; 1979; 26(4):405-12. PubMed ID: 160510
[TBL] [Abstract][Full Text] [Related]
34. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
Law LW
Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
[TBL] [Abstract][Full Text] [Related]
35. Tumor-associated transplantation antigen distinct from H-2k-like antigens on a BALB/c (H-2d) fibrosarcoma.
Parmiani G; Meschini A; Invernizzi G; Carbone G
J Natl Cancer Inst; 1978 Nov; 61(5):1229-34. PubMed ID: 81882
[No Abstract] [Full Text] [Related]
36. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. II. In vitro serological studies.
Invernizzi G; Carbone G; Parmiami G
Tumori; 1977; 63(2):181-94. PubMed ID: 898289
[No Abstract] [Full Text] [Related]
37. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
Leffell MS; Coggin JH
Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
[No Abstract] [Full Text] [Related]
38. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
Evans R
Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
[TBL] [Abstract][Full Text] [Related]
39. Antibody-induced redistribution of normal and tumor associated surface antigens.
Yefenof E; Klein G
Exp Cell Res; 1974 Oct; 88(2):217-24. PubMed ID: 4372068
[No Abstract] [Full Text] [Related]
40. Generation of crossreacting tumor antigens in ascitic derivatives from murine methylcholanthrene-induced sarcomas.
Law LW
Int J Cancer; 1984 Apr; 33(4):547-51. PubMed ID: 6200449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
